47° and Overcast
Image
Boston Scientific Unveils $170 Million Maple Grove Campus
Maple Grove, MN — Medical device giant Boston Scientific officially celebrated the grand opening of its $170 million campus in Maple Grove, Minnesota, marking a major expansion of the company’s footprint in the state. The 400,000-square-foot facility, formerly known by the codename “Project Black Bear,” opened Monday with a ribbon-cutting ceremony attended by Minnesota Governor Tim Walz and other state and local dignitaries.
The new campus, built on a former gravel mining site near Interstate 694 and Highway 169, is designed as a hub for research, development, and corporate operations. It will house more than 1,500 employees and serve as a divisional headquarters for Boston Scientific’s cardiovascular business, which produces devices such as stents and pacemakers. The campus also includes office space, laboratories, quality-assurance testing areas, and an on-site innovation center.
“This is a win for Boston Scientific, it’s a win for Maple Grove, it’s a win for Minnesota, but it’s a win for folks around the world who are going to benefit from this technology that improves lives,” Gov. Walz said during the ceremony, highlighting the global significance of the investment.
Strategic Location and Economic Impact
Maple Grove was a strategic choice for the campus, as Boston Scientific is already the city’s largest employer, with approximately 4,000 employees in the area. The company reportedly considered alternate locations in Massachusetts and Alpharetta, Georgia, before selecting Maple Grove, where it could consolidate and expand research, engineering, and testing functions.
The project is expected to create hundreds of new jobs while retaining roughly 1,000 existing positions that might otherwise have been relocated. Financial support from the state, including funds from the Job Creation Fund and the Minnesota Investment Fund, helped facilitate the development.
Maple Grove Mayor Mark Steffenson praised the project, emphasizing the city’s role as a growing hub for medical technology. “There are really truly few places in the world where industry can come together as we’ve developed here in Maple Grove and as we’ve developed here in Minnesota,” he said.
The campus strengthens Maple Grove’s position as a regional center for life sciences and medical technology innovation. It will join Boston Scientific’s existing local operations, further supporting the company’s global cardiovascular product lines while contributing to the ongoing development of the Minnesota Science and Technology Center.
